COMMUNIQUÉS West-GlobeNewswire

Announcement no. 13/2017 - Coloplast A/S acquires SAS Lilial
18/12/2017
Coloplast A/S acquires SAS Lilial Coloplast A/S announced today that it has entered into a definitive agreement to acquire SAS Lilial (Lilial) for a cash consideration of EUR 35.5m equal to approx. DKK 264m on a cash [...]
Board of Olainfarm Will be Chaired by Olegs Grigorjevs
18/12/2017
Olaine, 2017-12-18 15:27 CET (GLOBE NEWSWIRE) -- Olegs Grigorjevs was Executive Director of AS Olainfarm and the Member of the Board with more than 20 years of experience in chemical and pharmaceutical sector. O. [...]
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018
18/12/2017
NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]
Advantis Corp. Expects Quarterly Revenue Records Throughout 2018
18/12/2017
Newport Beach, CA , Dec. 18, 2017 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT ) CEO, Darren Cherry, took a moment to review the progress the company has made this year, and lays out an achievable set of [...]
Orion Corporation: Managers' transactions - Huhta-Koivisto Tero
18/12/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 16.00 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Tero Orion Corporation has received the following disclosure under Market Abuse [...]
La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC‑401 in Patients with Hereditary Hemochromatosis
18/12/2017
SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (NASDAQ: LJPC ) (the Company or La Jolla) today announced the initiation of LJ401-HH01, a Phase 2 clinical study of LJPC‑401 (synthetic human [...]
athenahealth to Present at the 36th Annual J.P. Morgan Healthcare Conference
18/12/2017
WATERTOWN, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that Jonathan Bush, [...]
Orion Corporation: Managers' transactions - Huhta-Koivisto Kalle
18/12/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 15.50 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Kalle Orion Corporation has received the following disclosure under Market Abuse [...]
Orion Corporation: Managers' transactions - Huhta-Koivisto Esko kuolinpesä
18/12/2017
ORION CORPORATION MANAGERS' TRANSACTIONS 18 DECEMBER 2017 at 15.45 EET Orion Corporation: Managers' transactions - Huhta-Koivisto Esko kuolinpesä Orion Corporation has received the following disclosure under Market [...]
RespireRx Pharmaceuticals Inc. Publishes Compelling Scientific Evidence Demonstrating the Neurobiological Safety of Ampakine CX717 and Justifying Continued Clinical Development
18/12/2017
Glen Rock, N.J., Dec. 18, 2017 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), is pleased to announce that a paper detailing the neurobiologic safety of the ampakine [...]
United Health Products Completes Multiple FDA Required Tests for HemoStyp®
18/12/2017
HENDERSON, Nev., Dec. 18, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]
EyeGate Achieves 75% Enrollment in Pivotal Phase 3 Clinical Trial for Anterior Uveitis Triggering Milestone Payment
18/12/2017
WALTHAM, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two platform technologies for [...]
Ultragenyx Sells Priority Review Voucher for $130 million
18/12/2017
NOVATO, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]
New Biomarker Data Supports Direct Link between VB-111’s Dual Mechanism of Action and its Clinical Effect on Overall Survival and Progression Free Survival in Recurrent Glioblastoma Multiforme Patients
18/12/2017
TEL AVIV, Israel, Dec. 18, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), announced new biomarker data supporting the direct link between lead asset VB-111’s dual mechanism of action and clinical effect on [...]
Novo Nordisk A/S: Share repurchase programme
18/12/2017
Bagsværd, Denmark, 18 December 2017 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Horizon Health Network and Service New Brunswick extend Allscripts Sunrise™ commitment
18/12/2017
RICHMOND, British Columbia, Dec. 18, 2017 (GLOBE NEWSWIRE) -- In the fourth quarter of 2017, Horizon Health Network and Service New Brunswick extended its contract term with Allscripts through 2024, to further clinical [...]
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 29, 2017
18/12/2017
BETHESDA, Md., Dec. 18, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), adjourned again the voting for Proposals Three and Four from its Notice of Annual Meeting of Shareholders, dated [...]
Poseida Therapeutics Announces First Patient Treated in Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Therapy in Patients with Multiple Myeloma
18/12/2017
SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]
Uptick Newswire “Stock Day” Interviews CEO of Lexaria on Cannabis Related Products and Recent Bioscience Patents
18/12/2017
Phoenix, AZ, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast and after airing back in January 2016 CEO and host Everett Jolly has interviewed hundreds of [...]

Pages